Sequential signaling cascade of IL-6 and PGC-1α is involved in high glucose-induced podocyte loss and growth arrest

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 702-707

  Kim, Dong Il ^a   Park, Soo Hyun ^a  

^a Chonnam National University   (South Korea)

Author keywords

Cell arrest; Diabetic nephropathy; Interleukin 6; PGC 1 ; Podocyte loss

Indexed keywords

GLUCOSE; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; CYTOKINE RELEASE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH DISORDER; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOCYTE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; GLUCOSE; INTERLEUKIN-6; PODOCYTES; RATS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

RATTUS;

EID: 84878981482     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.046     Document Type: Article

References (27)

1. Satchell S.C. The glomerular endothelium emerges as a key player in diabetic nephropathy. Kidney Int. 2012, 82:949-951.
2. Miyauchi M., Toyoda M., Kobayashi K., Abe M., Kobayashi T., Kato M., Yamamoto N., Kimura M., Umezono T., Suzuki D. Hypertrophy and loss of podocytes in diabetic nephropathy. Intern. Med. 2009, 48:1615-1620.
3. Menini S., Iacobini C., Oddi G., Ricci C., Simonelli P., Fallucca S., Grattarola M., Pugliese F., Pesce C., Pugliese G. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Diabetologia 2007, 50:2591-2599.
4. Kuan C.J., al-Douahji M., Shankland S.J. The cyclin kinase inhibitor p21WAF1, CIP1 is increased in experimental diabetic nephropathy: potential role in glomerular hypertrophy. J. Am. Soc. Nephrol. 1998, 9:986-993.
5. Muller-Krebs S., Kihm L.P., Madhusudhan T., Isermann B., Reiser J., Zeier M., Schwenger V. Human RAGE antibody protects against AGE-mediated podocyte dysfunction. Nephrol. Dial. Transpl. 2012, 27:3129-3136.
6. Fujio Y., Maeda M., Mohri T., Obana M., Iwakura T., Hayama A., Yamashita T., Nakayama H., Azuma J. Glycoprotein 130 cytokine signal as a therapeutic target against cardiovascular diseases. J. Pharmacol. Sci. 2011, 117:213-222.
7. Esterbauer H., Oberkofler H., Krempler F., Patsch W. Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization and tissue expression. Genomics 1999, 62:98-102.
8. Canto C., Auwerx J. PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 2009, 20:98-105.
9. Shoag J., Arany Z. Regulation of hypoxia-inducible genes by PGC-1 α. Arterioscler., Thromb., Vasc. Biol. 2010, 30:662-666.
10. Benton C.R., Holloway G.P., Han X.X., Yoshida Y., Snook L.A., Lally J., Glatz J.F., Luiken J.J., Chabowski A., Bonen A. Increased levels of peroxisome proliferator-activated receptor gamma, coactivator 1 α (PGC-1α) improve lipid utilisation, insulin signalling and glucose transport in skeletal muscle of lean and insulin-resistant obese Zucker rats. Diabetologia 2010, 53:2008-2019.
11. Kreisberg J.I., Hoover R.L., Karnovsky M.J. Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int. 1978, 14:21-30.
12. Souza J.R., Oliveira R.T., Blotta M.H., Coelho O.R. Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation. Arq. Bras. Cardiol. 2008, 90:86-90.
13. Taslipinar A., Yaman H., Yilmaz M.I., Demirbas S., Saglam M., Taslipinar M.Y., Agilli M., Kurt Y.G., Sonmez A., Azal O., Bolu E., Yenicesu M., Kutlu M. The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy. Scand. J. Clin. Lab. Inv. 2011, 71:606-612.
14. Lim S.K., Park S.H. The high glucose-induced stimulation of B1R and B2R expression via CB(1)R activation is involved in rat podocyte apoptosis. Life Sci. 2012, 91:895-906.
15. Mitu G.M., Wang S., Hirschberg R. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am. J. Physiol. Ren. Physiol. 2007, 293:F1641-F1648.
16. Peixoto E.B., Papadimitriou A., Lopes de Faria J.M., Lopes de Faria J.B. Tempol reduces podocyte apoptosis via PARP signaling pathway in experimental diabetes mellitus. Nephron Exp. Nephrol. 2012, 120:e81-e90.
17. Tikoo K., Singh K., Kabra D., Sharma V., Gaikwad A. Change in histone H3 phosphorylation, MAP kinase p38, SIR 2 and p53 expression by resveratrol in preventing streptozotocin induced type I diabetic nephropathy. Free Radic. Res. 2008, 42:397-404.
18. Gao F., Yao M., Shi Y., Hao J., Ren Y., Liu Q., Wang X., Duan H. Notch pathway is involved in high glucose-induced apoptosis in podocytes via Bcl-2 and p53 pathways. J. Cell. Biochem. 2013, 114:1029-1038.
19. Sun L., Kondeti V.K., Xie P., Raparia K., Kanwar Y.S. Epac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathway. Am. J. Pathol. 2011, 179:1706-1718.
20. Huang J.S., Chuang L.Y., Guh J.Y., Huang Y.J., Hsu M.S. Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells. Am. J. Physiol. Ren. Physiol. 2007, 293:F1072-F1082.
21. Baba M., Wada J., Eguchi J., Hashimoto I., Okada T., Yasuhara A., Shikata K., Kanwar Y.S., Makino H. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms. J. Am. Soc. Nephrol. 2005, 16:3222-3234.
22. Schreiber S.N., Knutti D., Brogli K., Uhlmann T., Kralli A. The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor α (ERRalpha). J. Biol. Chem. 2003, 278:9013-9018.
23. Schilling J., Kelly D.P. The PGC-1 cascade as a therapeutic target for heart failure. J. Mol. Cell. Cardiol. 2011, 51:578-583.
24. Koo S.H., Satoh H., Herzig S., Lee C.H., Hedrick S., Kulkarni R., Evans R.M., Olefsky J., Montminy M. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 2004, 10:530-534.
25. Gao C.L., Zhu C., Zhao Y.P., Chen X.H., Ji C.B., Zhang C.M., Zhu J.G., Xia Z.K., Tong M.L., Guo X.R. Mitochondrial dysfunction is induced by high levels of glucose and free fatty acids in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 2010, 320:25-33.
26. Wareski P., Vaarmann A., Choubey V., Safiulina D., Liiv J., Kuum M., Kaasik A. PGC-1α and PGC-1β regulate mitochondrial density in neurons. J. Biol. Chem. 2009, 284:21379-21385.
27. Mirebeau-Prunier D., Le Pennec S., Jacques C., Gueguen N., Poirier J., Malthiery Y., Savagner F. Estrogen-related receptor α and PGC-1-related coactivator constitute a novel complex mediating the biogenesis of functional mitochondria. FEBS J. 2010, 277:713-725.